Global & Disaster Medicine

Archive for the ‘Uncategorized’ Category

Indonesia: Child sex abuse is now punishable by death and chemical castration

CNN

The new law was issued by the president following the brutal gang rape and murder of a 14-year-old girl.

 


A review on American (home-grown) extremism

Washington Post

“……Much of the movement traces its roots to the deadly 1990s confrontations between civilians and federal agents at Ruby Ridge, Idaho, and in Waco, Tex., that resulted in the deaths of as many as 90.

Timothy Mc­Veigh cited both events before he was executed for the 1995 Oklahoma City bombing that killed 168 people, and said he had deliberately chosen a building housing federal government agencies.

Now a “Second Wave” is spreading across the country…..”

Antigovernment "Patriot" Groups, Militia Count 2015

Southern Poverty Law Center


March 25: CDC Issues Updated Zika Recommendations

CDC

CDC Issues Updated Zika Recommendations: Timing of Pregnancy after Zika Exposure, Prevention of Sexual Transmission, Considerations for Reducing Unintended Pregnancy in Areas with Zika Transmission

 

For Immediate Release: Friday, March 25, 2016
Contact: Media Relations,
(404) 639-3286

CDC today issued new guidance and information to prevent Zika virus transmission and health effects:

  • Updated interim guidance for healthcare professionals for counseling patients about pregnancy planning and the timing of pregnancy after possible exposure to Zika virus;
  • Updated interim guidance for preventing sexual transmission with information about how long men and women should consider using condoms or not having sex; and
  • Considerations and challenges, based on Puerto Rico’s experience, for reducing unintended pregnancy in areas with active Zika transmission.

CDC updates its interim guidance related to Zika virus transmission and related health effects based on the accumulating evidence, expert opinion, and knowledge about the risk associated with other viral infections. CDC will continue to update this guidance as new information becomes available.

Article 1: Updated interim guidance for pregnant and reproductive age women

Mounting evidence supports a link between Zika and microcephaly, a birth defect that is a sign of incomplete brain development, and possibly other problems such as miscarriage and stillbirth. The rate of these complications is not known but is being studied further.  Importantly, even in places with active Zika transmission women are delivering apparently healthy infants. Healthcare providers need clear guidance to inform discussions with their patients about possible exposure to Zika virus, pregnancy planning, and timing of pregnancy. The updated CDC recommendations are these:

  • For women and men who have been diagnosed with Zika virus or who have symptoms of Zika including fever, rash, joint pain or red eyes after possible exposure to Zika virus, CDC recommends healthcare providers advise:
    • Women wait at least 8 weeks after their symptoms first appeared before trying to get pregnant.
    • Men wait at least 6 months after their symptoms first appeared to have unprotected sex.
    • In making these recommendations, we considered the longest known risk period for these categories. We then allowed for three times the known period of time.
  • For men and women without symptoms of Zika virus but who had possible exposure to Zika from recent travel or sexual contact, CDC recommends healthcare providers advise their patients wait at least 8 weeks after their possible exposure before trying to get pregnant in order to minimize risk.
  • For men and women without symptoms of Zika virus who live in an area with active Zika transmission, CDC recommends healthcare providers talk with their patients about their pregnancy plans during a Zika virus outbreak, the potential risks of Zika, and how they can prevent Zika virus infection.  These are very complex, deeply personal decisions, and we are communicating the potential risks of Zika virus infection during pregnancy for people who live in areas with active transmission.  We are encouraging health care providers to have conversations with women and their partners about pregnancy planning, their individual circumstances and strategies to prevent unintended pregnancies.

Men and women who reside in areas with active Zika virus transmission who are considering pregnancy need clear guidance to help inform the deeply personal and very complex decision about timing of pregnancy.  Conversations about health risks of pregnancy can be very difficult, but are important to have.  Healthcare providers should discuss the risks of Zika, emphasize ways to prevent Zika virus infection, and provide information about safe and effective contraceptive methods.  As part of their pregnancy planning and counseling with their health care providers, some women and their partners residing in areas with active Zika virus transmission may decide to delay pregnancy.

Article 2: Updated interim guidance for preventing sexual transmission of Zika

The recommendations for men who live in or travel to an area with active Zika virus transmission who have a pregnant partner remain the same:  CDC recommends that men with a pregnant partner should use condoms every time they have sex or not have sex for the duration of the pregnancy. To be effective, condoms must be used correctly from start to finish, every time during sex. This includes vaginal, anal or oral (mouth-to-penis) sex.

The updated guidance includes new timeframes for men and their non-pregnant partners based on the couple’s situation, including whether the man lives in or has traveled to an area with active Zika virus transmission and whether he develops symptoms of possible Zika infection. The guidance is based on available information about how long the virus remains in semen and the risks associated with Zika based on whether or not men had symptoms of infection:

  • Couples with men who have confirmed Zika or symptoms of Zika should consider using condoms or not having sex for at least 6 months after symptoms begin. This includes men who live in and men who traveled to areas with Zika.
  • Couples with men who traveled to an area with Zika but did not develop symptoms of Zika should consider using condoms or not having sex for at least 8 weeks after their return in order to minimize risk.
  • Couples with men who live in an area with Zika but have not developed symptoms might consider using condoms or not having sex while there is active Zika transmission in the area.

Couples who do not want to get pregnant should use the most effective contraceptive methods that they can use consistently and correctly, and they should also use condoms to prevent the sexual transmission of Zika. Couples who are trying to get pregnant should consult with their healthcare provider.

Article 3: Increasing access to contraception in areas with active Zika transmission

Because of the potential for Zika virus to affect pregnant women and their fetuses, strategies to prevent unintended pregnancy are a critical part of current efforts to prevent Zika-related health effects. Based on Puerto Rico’s experience, CDC has identified considerations and challenges in reducing unintended pregnancies in areas with active Zika transmission.

Approximately two-thirds of pregnancies in Puerto Rico are unintended, indicating a potentially unmet need for access to birth control. In this report, researchers estimated that about 138,000 women in Puerto Rico may be at risk of unintended pregnancy and are not using one of the most effective or moderately effective forms of birth control. In areas with active Zika transmission, women and their partners who do not want to get pregnant now should be advised about the range of effective birth control methods and counseled that correct and consistent use of these methods is important if they do not want to become pregnant.

The Department of Health and Human Services (HHS) is working to leverage existing programs that currently provide resources for or access to contraception in Puerto Rico, including programs administrated by the Health Resources and Services Administration (HRSA), Office of Population Affairs (OPA) within the Office of the Assistant Secretary for Health (OASH), and Centers for Medicare & Medicaid Services (CMS). HHS is also coordinating with federal, local, and private partners to identify additional resources to support increased access to the most effective forms of contraception.

HRSA has 20 health center grantees that operate 84 sites in Puerto Rico, which serve over 330,000 people, including nearly 80,000 women ages 15 to 45. HHS is exploring possible expansion of services at these centers, which currently include prenatal care and other voluntary family planning services. OPA is working to provide additional funds for contraceptive services, as well as facilitate the training of providers in long-acting reversible contraception methods. OPA supports two Title X grantees that operate 15 clinics in Puerto Rico, which serve over 19,000 people. Family planning services are a mandatory benefit under Medicaid for women and men, and are exempt from cost-sharing requirements. CMS is working to provide additional guidance to states and territories on how their Medicaid programs can support the Zika response, including coverage for contraception.

CDC will continue to update its guidance related to Zika virus transmission and related health effects based on the accumulating evidence, expert opinion, and knowledge about the risk associated with other viral infections. For updates, visit: http://www.cdc.gov/zika/index.html.

###


WHO: Tools prioritized as the most viable options to help fight the spread of Zika virus in the immediate future:

WHO

 

WHO and experts prioritize vaccines, diagnostics and innovative vector control tools for Zika R&D

67 groups working on experimental products


9 March 2016

After a three-day consultation on Zika research and development, international experts, convened by WHO, have agreed on top priorities to advance R&D for Zika medical products.

The following tools were prioritized as the most viable options to help fight the spread of Zika virus in the immediate future:

  • Multiplex tests for ‘flaviviruses’ (viruses related to Zika, such as dengue, chikungunya), in addition to more traditional tests;
  • protective vaccines based on killed virus (or other non-live) preparations for women of childbearing age; and
  • innovative vector control tools that reduce the mosquito population.

“Zika virus induces a mild and mostly harmless infection in the majority of patients,” indicated Dr Marie-Paule Kieny, Assistant Director-General in charge of R&D at WHO. “For that reason medicines to treat it seem less of a priority at this stage. The most pressing need is the development of diagnostic and preventive tools to address the current R&D gap and protect pregnant women and their babies.”

As of 2 March, 67 companies and research institutions were already working on a number of products (31 on diagnostics, 18 on vaccines, 8 on therapeutics, 10 on vector control), which are at various stages of early development. No vaccine or therapeutic has yet been tested on humans.

Vaccines

Experts agreed that the development of a vaccine is a major priority to respond to epidemics in the future. Vaccination of pregnant women and women of childbearing age is the main target, and pragmatic strategies will be needed to fast-track the development of a safe and effective product.

Work is underway for the development of an emergency vaccine target product profile. The target product profile will serve as a guide to consult and build consensus on regulatory requirements for Zika vaccine evaluation and registration. A draft target profile will be submitted to a public consultation in the coming weeks, with a view to having a final profile in May.

Diagnostics

Over 30 companies are working on or have developed potential diagnostic tests. There is general support for the development of a target product profile for a multiplex test that can diagnose dengue, chikungunya and Zika viruses. A first draft is ready and this too will undergo public consultation before finalization in mid-April.

WHO continues to encourage manufacturers to apply to the WHO Emergency Use, Assessment and Listing procedure for a quality and performance evaluation of their products.

Vector control

Vector control experts have clearly stated that as traditional interventions – such as insecticide spraying – have not had significant impact on dengue transmission the same might apply to Zika. They also cautioned that extreme rigour needs to be applied in evaluating novel tools, such as Wolbachia, recombinant and irradiated mosquitoes. An emergency meeting of the WHO Vector Control Advisory Group next week will fine-tune evaluation methods and a target product profile for innovative techniques.

The R&D community has responded vigorously to the need for Zika medical products and innovative vector control measures; the pipeline of candidate products is still growing. A major advance compared to the Ebola product R&D response of 2014-2015 is the speed with which data and experiences are being shared across countries.

“While product development is at an earlier stage than that for Ebola,” concluded Dr Marie-Paule Kieny, “R&D methods and coordination among partners is much more advanced, largely thanks to the lessons learnt during the Ebola epidemic.”


Uganda: Mortality in Children Under Five Receiving Nonphysician Clinician Emergency Care

Mortality in Children Under Five Receiving Nonphysician Clinician Emergency Care in Uganda
Brian Rice, Usha Periyanayagam, Stacey Chamberlain, Bradley Dreifuss,
Heather Hammerstedt, Sara Nelson, Samuel Maling, and Mark Bisanzo
Pediatrics 2016; 137:1-8

http://pediatrics.aappublications.org/content/137/3/1.43.abstract?etoc

“…..No significant mortality difference was seen between supervised and unsupervised care (2.17% vs 3.01%, P = .43) for the majority of patients that were not severely ill. Severely ill patients analyzed separately showed a significant mortality difference (4.07% vs 10.3%, P = .01). Logistic regression revealed physician supervision significantly reduced mortality for patients overall (odds ratio = 0.52, P = .03), but not for nonseverely ill patients analyzed separately (odds ratio = 0.73, P = .47)…..”

 


India: A man fatally stabbed 14 members of his family, including seven children, early Sunday before hanging himself.

CBS

 


Italy: A 50-year-old Tuscan woman contracted meningitis C, bringing the total cases of meningitis in the region to 12 thus far this year.

ANSA

Italy at Night

 


Soil Composition Across the U.S.

Soil Composition Across the U.S.


Paris: On the anniversary of Charlie Hebedo

 


Philippines: A man was killed and more than 380 others were injured by firecrackers on New Year’s Eve

USA Today

**  “….Officials said the number of people injured was 53% lower than the previous year, because of rain and a government campaign to warn people of the dangers of firecrackers….”

Date: 04/01/2014 Description: Map of the Philippines © CIA World Factbook

 


Categories

Recent Posts

Archives

Admin